Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryoport (CYRX) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Cryoport (CYRX) over the last 17 years, with Q3 2025 value amounting to $255.8 million.

  • Cryoport's Cash & Equivalents rose 47273.26% to $255.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $255.8 million, marking a year-over-year increase of 47273.26%. This contributed to the annual value of $45.3 million for FY2024, which is 228.07% down from last year.
  • Cryoport's Cash & Equivalents amounted to $255.8 million in Q3 2025, which was up 47273.26% from $243.4 million recorded in Q2 2025.
  • Cryoport's Cash & Equivalents' 5-year high stood at $353.2 million during Q1 2021, with a 5-year trough of $30.7 million in Q3 2022.
  • Moreover, its 5-year median value for Cash & Equivalents was $49.7 million (2024), whereas its average is $125.0 million.
  • Per our database at Business Quant, Cryoport's Cash & Equivalents crashed by 9120.87% in 2022 and then soared by 47273.26% in 2025.
  • Cryoport's Cash & Equivalents (Quarter) stood at $139.1 million in 2021, then tumbled by 73.69% to $36.6 million in 2022, then rose by 26.65% to $46.3 million in 2023, then decreased by 2.28% to $45.3 million in 2024, then soared by 464.84% to $255.8 million in 2025.
  • Its Cash & Equivalents stands at $255.8 million for Q3 2025, versus $243.4 million for Q2 2025 and $47.4 million for Q1 2025.